Application Information

This drug has been submitted to the FDA under the reference 022000/001.

Names and composition

"LIALDA" is the commercial name of a drug composed of MESALAMINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022000/001 LIALDA MESALAMINE TABLET, DELAYED RELEASE/ORAL 1.2GM

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
019618/001 ROWASA MESALAMINE ENEMA/RECTAL 4GM per 60ML
019618/002 SFROWASA MESALAMINE ENEMA/RECTAL 4GM per 60ML
019651/001 ASACOL MESALAMINE TABLET, DELAYED RELEASE/ORAL 400MG
019919/001 ROWASA MESALAMINE SUPPOSITORY/RECTAL 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
020049/001 PENTASA MESALAMINE CAPSULE, EXTENDED RELEASE/ORAL 250MG
020049/002 PENTASA MESALAMINE CAPSULE, EXTENDED RELEASE/ORAL 500MG
021252/001 CANASA MESALAMINE SUPPOSITORY/RECTAL 500MG
021252/002 CANASA MESALAMINE SUPPOSITORY/RECTAL 1GM
021830/001 ASACOL HD MESALAMINE TABLET, DELAYED RELEASE/ORAL 800MG
022000/001 LIALDA MESALAMINE TABLET, DELAYED RELEASE/ORAL 1.2GM
022301/001 APRISO MESALAMINE CAPSULE, EXTENDED RELEASE/ORAL 375MG
076751/001 MESALAMINE MESALAMINE ENEMA/RECTAL 4GM per 60ML
076841/001 MESALAMINE MESALAMINE ENEMA/RECTAL 4GM per 60ML
091640/001 MESALAMINE MESALAMINE TABLET, DELAYED RELEASE/ORAL 1.2GM
202065/001 MESALAMINE MESALAMINE SUPPOSITORY/RECTAL 1000MG
203286/001 MESALAMINE MESALAMINE TABLET, DELAYED RELEASE/ORAL 800MG
204354/001 MESALAMINE MESALAMINE SUPPOSITORY/RECTAL 1GM
204412/001 DELZICOL MESALAMINE CAPSULE, DELAYED RELEASE/ORAL 400MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved